|Awarded On||November 29, 2017|
|Title||STOP HCC-HCV Prevention Program Dissemination Project|
|Award Mechanism||Dissemination of CPRIT-Funded Cancer Control Interventions|
|Institution/Organization||The University of Texas Health Science Center at San Antonio|
|Principal Investigator/Program Director||Barbara J Turner|
|Cancer Sites||Gallbladder, Liver and Intrahepatic Bile Duct|
Hepatitis C virus (HCV) infection is the primary cause of a rapidly increasing cancer, hepatocellular carcinoma (HCC). Texas leads the nation in HCC mortality and must lead in HCC prevention to reduce this threat. Through a CPRIT grant and other funded projects, we have developed the STOP HCC-HCV Prevention Program to implement national guidelines to screen all baby born boomers (BBs) born from 1945-65 for HCV. This birth cohort has 75% of all HCV infections in the U.S.
STOP HCC-HCV has demonstrated replicability and scalability based on its success in BB screening and linkage to care in 37 primary care clinics within 9 health care systems. To date, 35,885 BBs have been screened for HC...